Linked Life Data

14742993

Source:http://linkedlifedata.com/resource/pubmed/id/14742993

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2004-1-26
pubmed:abstractText
Dysregulated fibroblast proliferation is thought to play an important role in the progression of bronchiolitis obliterans (BO) after lung transplantation. Augmented immunosuppression is often used to treat BO. We investigated the effect of methylprednisolone (mPRED), cyclosporine A (CsA), tacrolimus (FK506), azathioprine (AZA), mycophenolate mofetil (MMF), and everolimus (rapamycin derivative [RAD]) on the proliferative capacity of fibroblasts cultured from transbronchial biopsies of lung transplant recipients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0041-1337
pubmed:author
pubmed:issnType
Print
pubmed:day
27
pubmed:volume
77
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
275-80
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:14742993-Adult, pubmed-meshheading:14742993-Aged, pubmed-meshheading:14742993-Azathioprine, pubmed-meshheading:14742993-Bronchi, pubmed-meshheading:14742993-Bronchiolitis Obliterans, pubmed-meshheading:14742993-Cell Division, pubmed-meshheading:14742993-Cells, Cultured, pubmed-meshheading:14742993-Cyclosporine, pubmed-meshheading:14742993-Female, pubmed-meshheading:14742993-Fibroblasts, pubmed-meshheading:14742993-Humans, pubmed-meshheading:14742993-Immunosuppressive Agents, pubmed-meshheading:14742993-Infection, pubmed-meshheading:14742993-Lung Diseases, pubmed-meshheading:14742993-Lung Transplantation, pubmed-meshheading:14742993-Male, pubmed-meshheading:14742993-Middle Aged, pubmed-meshheading:14742993-Mycophenolic Acid, pubmed-meshheading:14742993-Postoperative Complications, pubmed-meshheading:14742993-Sirolimus, pubmed-meshheading:14742993-Tacrolimus
pubmed:year
2004
pubmed:articleTitle
Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.
pubmed:affiliation
The Lung Transplant Unit, St. Vincent's Hospital, Sydney, Australia. azzolaa@uhbs.ch
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't